Kent Lake Capital »

Akoya Biosciences shares owned by Kent Lake Capital

Quarter-by-quarter ownership of Akoya Biosciences (AKYA) shares owned by Kent Lake Capital from 13F filings

Historical chart of Kent Lake Capital investment in Akoya Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Akoya Biosciences held by Kent Lake Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akoya Biosciences by Kent Lake Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $570k 117k 4.88
2023-09-30 $3.5M 747k 4.65

More positions owned by Kent Lake Capital

Zimvie (ZIMV)
Allscripts Healthcare Solutions (MDRX)
Kyndryl Hldgs Common Stock (KD)
Vericel (VCEL)
FARO Technologies (FARO)
8x8 (EGHT)
Innovage Hldg Corp (INNV)
Ensign (ENSG)
Upwork (UPWK)
Nerdy Cl A Com (NRDY)
Fiverr Intl Ord Shs (FVRR)
Calavo Growers (CVGW)
Pennant Group (PNTG)
Si-bone (SIBN)
Caredx (CDNA)

View all positions for Kent Lake Capital

Top funds holding Akoya Biosciences

Blue Water Life Science Advisors
Vanguard Group
Board of Trustees of The Leland Stanford Junior University
Bp Wealth Management
Peddock Capital Advisors
Charles Schwab Investment Management
Millennium Management
Schonfeld Strategic Advisors
Osterweis Capital Management
Kent Lake Capital
Squarepoint Ops
Bank of New York Mellon
ZWJ Investment Counsel
Barclays
Rhumbline Advisers

View all funds holding Akoya Biosciences